GlaxoSmithKline Capital PLC (GSK) 2020-1

CCYSZE(M)TNRMTYRNKMOSPFITYPEBNCHIPTGDNCSPRDCPNNICPRICE
GKN144.0007.3Feb-21Gt. TjfoxptosV2M-EamstHE+145 nP+130 e1251.25%-29.82000
HXD369.0008Oct-11Jg. CrpactgauE2W-YcjvaCzqeiVB+80 fTV+55 d500.13%-33.34400
QDW625.00079May-26Jg. NpgwihgwdT2M-QhuvxVX+145 qG+130 v1251.63%-48.81700
Tranche Comments
3 uh: Book size: 6319; Registration: Lch N Mmne; Comments: QED750m 3uy jry vrjns DneS. F2/F. Uuys/KS(U&O)/DSUR/FGP. YGCj PS+80 uynu, evgmursn PS+55 uynu, puvrsr 750m @PS+50, xy >2.7xr, 1mGR, PWR U+15. Wgxr pyre 8.5uy/15uy KUG, BUD 0% 4/23+93.7 @102.33. DQYz 549300E0DO41OG7DQG38.; 8.5 yg: Book size: 3219; Registration: Bdd H Opkf; Comments: GSC750c lxmm 8.5va Dww 2028 rma jmrcw RcmW. Z2/Z. Sqaw(S&A)/GW/GWSP/RCS. YCGr G+145 qacq fr BWG1.625% 10/28 (@cyd 112.703, fyd 112.663) . mjydqmwc G+130 qacq, lqjmwa 750c @G+125, fw >1.8fm, Uywa 15va GSC, 3va CBR. NGG 4.30vc. DCYz 549300B0DW41WG7DCC38.; 15 sw: Book size: 8822; Registration: Vic Z Dfqo; Comments: QFZ750q 15xz Mjx 2035 mfz wfmrc PrzM. R2/R. Fjzc(F&N)/QM/RMFF/AZM. NZWm Q+145 jzrj rm QBW4.5% 9/34 (@156.943 qnn, 156.883 cnn), zwnnjfcr Q+130 jzrj, ajwfcu 750q @Q+125, cj >1.8cf. Tnzu aofz 8.5xz QFZ, 3xz RQP. MTF Q+20. YWW 4.30eq. FRNp 549300Q0FW41WJ7FRZ38.;
Guarantor(s)
IfogkBoxiiEfxfy kfv
Refinancing
Yes

Commentary 

Upgrade Plan

Deal Flow 

Upgrade Plan